Skip to content

PIENTER-onderzoek

Third population-based immune surveillance study for the evaluation of the National Immunisation Programme in the Netherlands: the PIENTER3 study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON24544
Enrollment
8400
Registered
2016-01-05
Start date
2016-02-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The age-specific seroprevalence (immunity) for diseases included in the NIP of the Dutch general population

Interventions

None

Sponsors

National Institute for Public Health and the Environment (RIVM)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • Subject is part of the national study sample drawn from the population register, aged 0 to 89 year old and has received a personal invitation for the PIENTER study. • Subject has given written Informed Consent (IC) before the start of the study visit.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
The age-specific seroprevalence (immunity) for diseases included in the NIP of the Dutch general population.

Secondary

MeasureTime frame
The age-specific seroprevalence against other infectious diseases, in particular those that might be vaccine-preventable in the near future and against those diseases with a frequent subclinical course. By collecting additional samples, the relationship between immune status and carriage of potential pathogens, lifestyle factors and environmental factors can be studied.

Contacts

Public ContactR.A.J. Boxtel, van

Antonie van Leeuwenhoeklaan 9-11

renee.van.boxtel@rivm.nl+31 (0)30 2742755

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)